Staff20192020202120222023
Personnel at the end of the year5367667989
Staff turnover in EUR1,180,642943,970990,0611,086,3801,135,944
Turnover LabelEUREUREUREUREUR
The share: stated in EUR20192020202120222023
Shares outstanding (in mn.)0.0012.0012.0011.9912.00
Dividend per share---0.450.49
Basic earnings per share1.390.890.891.001.37
P/L in EUR million under IAS/IFRS20192020202120222023
Turnover62.663.265.385.8101.1
Operating income (EBIT)22.414.214.917.926.3
Earnings before taxes22.314.114.215.821.9
Annual net profit/ loss16.710.610.712.016.4
Balance sheet in EUR million under IAS/IFRS20192020202120222023
Assets
Total current assets102.122.432.551.562.8
Total fixed assets1.62.682.777.668.5
Total assets103.724.9115.3129.1131.3
Liabilities
Total short-term liabilities7.913.092.722.724.6
Total long-term liabilities0.20.40.375.367.0
Total provisions0.00.00.10.20.1
Equity capital95.611.522.231.139.8
Total liabilities103.724.9115.3129.1131.3
Management:
Natalie Weigand
Michael Rudolf
Board:
Clemens Fischer
Axel Rebien
Madlena Hohlefelder
Shareholding in %:
Aktia Varainhoito Oy 0.75
Clemens Fischer 80.1
Crédit Mutuel Asset Management SA 0.5
Fondita Fund Management Co. Ltd. 0.51
KBC Asset Management NV 0.11
Mandatum Life Sijoituspalvelut Oy 0.78
Principal Vermögensverwaltung AG 0.3
Schroder Investment Management Ltd. 0.48
UBS LA MAISON de Gestion 0.14
Union Investment Privatfonds GmbH 5.39
Freefloat 10.94
Address: Lochhamer Schlag 1, 82166 Graefelfing
T: +49-89-8589639-150
F: +49-89-8589639-201
I: http://pharmasgp.com
E: info@pharmasgp.com